CDX2 EXPRESSION

CI-VAR-00000934Explore in graph →CIViC 410

Curated evidence

Evidence by cancer (2 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–2 of 2 evidence items across 2 cancer contexts on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Malignant Colon Neoplasm1
CDX2 EXPRESSION	(prognostic)	Prognostic	B	Supports Better Outcome	4	rejected	EID1130 In patients with stage II colon cancer, positive CDX2 status was associated with longer overall survival. PMID 26789877 · Boland et al., 2016 · Open in CIViC	civic
Malignant Colorectal Neoplasm1
CDX2 EXPRESSION	(prognostic)	Prognostic	B	Supports Better Outcome	4	accepted	EID956 Patients with stage II/III colorectal cancer were analyzed for expression of CDX2 (by microarray and IHC). In the discovery (466 patients) and validation sets (314 patients), 5-year DFS was lower amon… (full text at CIViC) PMID 26789870 · Dalerba et al., 2016 · Open in CIViC

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.